SME technological innovation for biotechnology (Q2100935): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Created claim: summary (P836): The project will transfer research results from the collaboration between major regional biotechnology production companies and the KU and DTU to innovative SMEs and create new products and business opportunities. Products bring increased sustainability and competitiveness in biotechnology production. The project results in 12 new products in 12 SMEs, eight of which will be new spin-offs that will qualify for investment in terms of their product...)
(‎Changed an Item: Label in wikidata changed)
label / enlabel / en
 
SME technological innovation for biotechnology

Revision as of 12:49, 9 March 2020

Project in Denmark financed by DG Regio
Language Label Description Also known as
English
SME technological innovation for biotechnology
Project in Denmark financed by DG Regio

    Statements

    0 references
    20,348,800.0 Danish krone
    0 references
    2,645,344.0 Euro
    16 January 2020
    0 references
    40,697,601.0 Danish krone
    0 references
    5,290,688.13 Euro
    13 January 2020
    0 references
    50.0 percent
    0 references
    1 January 2015
    0 references
    31 August 2019
    0 references
    Spring Nordic ApS
    0 references

    55°39'0.4"N, 12°5'11.4"E
    0 references
    4000
    0 references
    Projektet vil overføre forskningsresultater fra samarbejdet mellem store regionale bioteknologiske produktionsvirksomheder og KU og DTU til innovative SMVer og skabe nye produkter og forretningsmuligheder. Produkterne skaber øget bæredygtighed og konkurrenceevne i bioteknologisk produktion. Projektet resulterer i 12 nye produkter hos 12 SMVere, hvoraf otte vil være nye spin-outs, der med deres produkt og forretningsplan vil kvalificere sig til at være investeringsegnede. Projektet vil skabe 100-200 arbejdspladser. Projektet tager afsæt i store produktionsvirksomheders behov for problemløsning. Dette sikrer, at løsninger er både markedsorienteret og har forskningshøjde. Output og resultater skabes i innovationssamarbejder mellem forskere fra DTU og KU, de store bioteknologiske producenter, som innovationslokomotiver og SMV teknologileverandører. CAPNOVA, der har indgående viden om kvalificering af SMVers forretnings- og udviklingspotentiale, sikrer fremdrift og resultatskabelse, der omsætter forskning til nye produkter og arbejdspladser i regionen og Danmark.Projektet går ind og støtter udnyttelsen af vækstmulighederne hos SMVer, baseret på efterspørgsel og et reelt marked blandt globale bioteknologiske produktionsvirksomheder.Fokus er udvikling af teknologiprodukter i SMVer. Dette sker gennem projektets hovedaktiviteter, der skitserer en innovationsproces med ét formål: At skabe produkter med et defineret marked. Projektet har fem hovedaktiviteter: 1. Markedsidentifikation 2. Identifikation af relevante SMVer med teknologisk udviklings- og produktionspotentiale.3. Feasibility studie for teknologiafklaring og projektgennemførelse blandt SMVer.4. Produktudvikling imellem smv, universitet og bioteknologiske virksomheder5. Information og kommunikation, samt vidensdeling til relevante aktører.Aktiviteterne er afgørende for projektets succes.Det er gennem ovenstående proces, at innovation og udvikling af nye produkter sker: - Nye udformninger af udstyr og produkter- Nye metoder til overførsel af procesviden fra forskning til fuldskala- Styrket videnopbygning og videnoverførsel. (Danish)
    0 references
    The project will transfer research results from the collaboration between major regional biotechnology production companies and the KU and DTU to innovative SMEs and create new products and business opportunities. Products bring increased sustainability and competitiveness in biotechnology production. The project results in 12 new products in 12 SMEs, eight of which will be new spin-offs that will qualify for investment in terms of their product and business plan. The project will create 100-200 jobs. The project is based on the need for large production companies to solve problems. This ensures that solutions are both market-oriented and have research into account. Outputs and results are generated in the innovation collaboration between DTU and KU researchers, the large biotech producers, as innovation locomotives and technology suppliers. The CAPNOVA, which has in-depth knowledge of the qualification of business and development potential of SMEs, provides momentum and results generation, translating research into new products and jobs in the region and the Danmark.The project is in favour of and supports the exploitation of the growth potential of SMEs, based on demand and a real market among global biotech production businesss.Focus is the development of technology products in SMEs. This is done through the main activities of the project, which outline an innovation process for one purpose: To create products with a defined market. The project has five main activities: 1 Market identification 2. Identification of the relevant SME with technological development and production potential.3. Feasibility study for technology clarification and project implementation among SMVer.4. Product development between SME, university and biotechnological enterprises5. Information and communication, as well as knowledge-sharing, to relevant activity.The activities are crucial to the success of the project. through the above process, innovation and the development of new products are done: — New forms of equipment and products- New methods for transferring process knowledge from research to full scale knowledge building and knowledge transfer. (English)
    0 references

    Identifiers

    179
    0 references